UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Clinical trial NCT06743503 · RECRUITING
Trial details
- NCT number
- NCT06743503
- Sponsor
- Nanjing IASO Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-11
- Primary completion
- 2028-05-21
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.